Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralization.

Saved in:
Bibliographic Details
Title: Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralization.
Authors: Konrath, Kylie M.1,2 (AUTHOR), Liaw, Kevin1 (AUTHOR), Tursi, Nicholas J.1,2 (AUTHOR), McCanna, Madison E.1 (AUTHOR), Warner, Bryce M.3,4,5 (AUTHOR), Gary, Ebony N.1 (AUTHOR), Zhu, Xizhou1 (AUTHOR), Livingston, Cory1 (AUTHOR), Monastra, Cara1 (AUTHOR), Frase, Drew1 (AUTHOR), Chokkalingam, Neethu1 (AUTHOR), Huynh, Alana1 (AUTHOR), Shupin, Nicholas1 (AUTHOR), Bayruns, Kelly1 (AUTHOR), Kriete, Sinja1 (AUTHOR), Kim, Amber1 (AUTHOR), Park, Joyce1 (AUTHOR), Vendramelli, Robert3 (AUTHOR), Truong, Thang3 (AUTHOR), Tierney, Kevin3 (AUTHOR)
Source: PLoS Pathogens. 2/19/2026, Vol. 22 Issue 2, p1-27. 27p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:15537366
DOI:10.1371/journal.ppat.1013905